Retinopathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) The patient was diagnosed with retinopathy by ophthalmology; 2) After examination rule out other organic eye diseases such as cataract glaucoma etc.; (3) Patients aged between 30 and 75 years old without serious systemic diseases were enrolled and stopped the drugs and other treatments that affected the efficacy observation of this study; (4) Inclusion criteria of the control group: meeting (1) (2) (3) and not accompanied by hypertension and diabetes; (5) Inclusion criteria for the diabetes group: it met (1) (2) and (3) and the diagnosis of diabetes mellitus and diabetic retinopathy (DR) and the international clinical classification of DR Was between mild and severe without hypertension; Hypertension group inclusion criteria: meet (1) (2) (3) and have a diagnosis of hypertension and do not have diabetes; The inclusion criteria of diabetes + hypertension group: meet (1) (2) (3) and the diagnosis of diabetes and diabetic retinopathy (DR) the international clinical classification of DR Is between mild and severe and meet the diagnostic criteria of hypertension; Blood sugar control is relatively stable (HBA1c is controlled below 7%); 9) Good compliance signed informed consent;
Exclusion criteria
Exclusion criteria: 1)Patients with other eye diseases (such as glaucoma moderate to severe cataract affecting fundus examination or other diseases that hinder the observation of fundus etc.); 2) Allergic patients who were allergic to sodium fluorescein injection and could not undergo fundus photography and fundus fluorescence angiography; 3) Patients with serious cardiovascular cerebrovascular liver or hematopoietic system diseases; 4) Patients with renal failure complicated with diabetic nephropathy; 5)Women and children who are breastfeeding pregnant or preparing to become pregnant cannot cooperate with treatment; 6) Patients who cannot follow medical instructions poor compliance hysteria or mental disorders; 7)Patients who are also participating in other clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| OCT examination;sight;Blood pressure;Low vision Quality of Life Scale;Fundus photography; | — |
Secondary
| Measure | Time frame |
|---|---|
| Self-efficacy scales;Cardiac speckle tracking imaging techniques;TCM Elements and Symptom Scores; | — |
Countries
China
Contacts
The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University